Use the search parameters below to filter talks:

Calendar
Calendar

2011 - IPITA - Prague (Prague, Czech Republic)

Parallel session 6 – Open mini-oral presentations Topic: Clinical and experimental islet transplantation
03 June 2011  /  11:00 - 12:00

The vasodilative and anti-cytokine induced cytoprotective effects by inhalative isoflurane on islet engraftment in the liver

Presenter: H. Yamaya, Sendai, Japan

- The vasodilative and anti-cytokine induced cytoprotective effects by inhalative isoflurane on islet engraftment in the liver

Presenter: H. Yamaya, Sendai, Japan

The caspase inhibitor IDN6556 enhances marginal mass islet engraftment in a mouse model of diabetes

Presenter: M.D. McCall, Edmonton, Canada

- The caspase inhibitor IDN6556 enhances marginal mass islet engraftment in a mouse model of diabetes

Presenter: M.D. McCall, Edmonton, Canada

Inhibition of human lymphocyte proliferation by small inhibitory molecules after stimulation with porcine cells in vitro

Presenter: G. Rayat, Edmonton, Canada

- Inhibition of human lymphocyte proliferation by small inhibitory molecules after stimulation with porcine cells in vitro

Presenter: G. Rayat, Edmonton, Canada

Human embryonic stem cell-derived therapy for diabetes: in vitro and in vivo assessments reveal distinct characteristics

Presenter: J. Gold, Chicago, USA

- Human embryonic stem cell-derived therapy for diabetes: in vitro and in vivo assessments reveal distinct characteristics

Presenter: J. Gold, Chicago, USA

Mesenchymal stem cells improve islet function and revascularisation

Presenter: C. Rackham, London, United Kingdom

- Mesenchymal stem cells improve islet function and revascularisation

Presenter: C. Rackham, London, United Kingdom

Systemic effects of liver regeneration on rat beta cells and islets: In vivo and in vitro studies

Presenter: F. Moreau, STRASBOURG, France

- Systemic effects of liver regeneration on rat beta cells and islets: In vivo and in vitro studies

Presenter: F. Moreau, STRASBOURG, France

Parallel session 7 – Open mini-oral presentations Topic: Islet transplantation: Technical aspects
03 June 2011  /  11:00 - 12:00

Molecular profiling demonstrates better outcomes for reversal of diabetes in long-term culture of neonatal islet cell clusters

Presenter: W.J Hawthorne, Westmead, Australia

- Molecular profiling demonstrates better outcomes for reversal of diabetes in long-term culture of neonatal islet cell clusters

Presenter: W.J Hawthorne, Westmead, Australia

Role of islet culture on angiogenic and inflammatory mechanisms

Presenter: A. Langlois, Strasbourg, France

- Role of islet culture on angiogenic and inflammatory mechanisms

Presenter: A. Langlois, Strasbourg, France

Inhibition of chloride ion influx into islet cells protects islets during pancreatic islet isolation

Presenter: T. Anazawa, Fukushima, Japan

- Inhibition of chloride ion influx into islet cells protects islets during pancreatic islet isolation

Presenter: T. Anazawa, Fukushima, Japan

IGL-1 preservation solution prevents lipidperoxidation and changes in membrane fluidity during pancreas allotransplant in pigs

Presenter: J. Escartín, Zaragoza, Spain

- IGL-1 preservation solution prevents lipidperoxidation and changes in membrane fluidity during pancreas allotransplant in pigs

Presenter: J. Escartín, Zaragoza, Spain

Designing polymer nanofiber scaffolds loaded with proangiogenic and immune modulatory compounds for islet transplant

Presenter: K. Brayman, Charlottesville, USA

- Designing polymer nanofiber scaffolds loaded with proangiogenic and immune modulatory compounds for islet transplant

Presenter: K. Brayman, Charlottesville, USA

Microencapsulation of the pancreatic islet within biofunctional GLP-1/PEG hydrogel

Presenter: I. Ergenc, Istanbul, Turkey

- Microencapsulation of the pancreatic islet within biofunctional GLP-1/PEG hydrogel

Presenter: I. Ergenc, Istanbul, Turkey

Parallel session 8 – Open mini-oral presentations Topic: Monitoring and assessment of the islet graft
03 June 2011  /  11:00 - 12:00

Acute cellular rejection of a pancreatic islet graft and rescue by steroid therapy: study of microparticles release in peripheral blood

Presenter: L. Kessler, Strasbourg, France

- Acute cellular rejection of a pancreatic islet graft and rescue by steroid therapy: study of microparticles release in peripheral blood

Presenter: L. Kessler, Strasbourg, France

Quantification of islet loss during immune rejection using iron-labeled islet cells by 3T MRI in the rat model

Presenter: S. Borot, GENEVA, Switzerland

- Quantification of islet loss during immune rejection using iron-labeled islet cells by 3T MRI in the rat model

Presenter: S. Borot, GENEVA, Switzerland

Assessment of tissue-engineered islet graft viability by fluorine magnetic resonance spectroscopy

Presenter: T.M. Suszynski, Minneapolis, USA

- Assessment of tissue-engineered islet graft viability by fluorine magnetic resonance spectroscopy

Presenter: T.M. Suszynski, Minneapolis, USA

In vitro labeling versus in vivo labeling of islets for PET Imaging after islet transplantation

Presenter: J. Lakey, Orange, USA

- In vitro labeling versus in vivo labeling of islets for PET Imaging after islet transplantation

Presenter: J. Lakey, Orange, USA

Human islets express a marked pro-inflammatory molecular signature prior to transplantation

Presenter: M. Cowley, Sydney, Australia

- Human islets express a marked pro-inflammatory molecular signature prior to transplantation

Presenter: M. Cowley, Sydney, Australia

Parallel session 9 – Open oral presentations Topic: Pancreas transplantation: Long-term function and rejection
03 June 2011  /  13:30 - 15:00

Single shot rATG (Thymoglobulin) successfully prevents rejection and immunologic graft loss in simultaneous pancreas kidney transplantation

Presenter: G. Woeste, Frankfurt, Germany

- Single shot rATG (Thymoglobulin) successfully prevents rejection and immunologic graft loss in simultaneous pancreas kidney transplantation

Presenter: G. Woeste, Frankfurt, Germany

Luminex screening for donor-specific anti-HLA antibodies in pancreas transplant alone

Presenter: F. Vistoli, Pisa, Italy

- Luminex screening for donor-specific anti-HLA antibodies in pancreas transplant alone

Presenter: F. Vistoli, Pisa, Italy

Diffuse C4d staining and not the presence of donor specific antibody (DSA) is associated with decreased pancreas allograft survival

Presenter: W. Manitpisitkul, Baltimore, USA

- Diffuse C4d staining and not the presence of donor specific antibody (DSA) is associated with decreased pancreas allograft survival

Presenter: W. Manitpisitkul, Baltimore, USA

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi